Molecular/genomic profiling is expanding precision selection of systemic therapy and may enable immunotherapy-driven organ ...

COLUMBUS, Ga. (WRBL) — In honor of May being Skin Cancer and Melanoma Awareness month, John B. Amos Center is offering locals ...

Balstilimab is a novel, fully human monoclonal immunoglobulin G4 (IgG4) designed to block PD-1 (programmed cell death protein 1) from interacting with its ligands PD-L1 and PD-L2. It has been ...

“I am truly overwhelmed by the love, support, prayers and messages I’ve received from so many people," the ESPN broadcaster said in a statement Ethan Miller/Getty Dick Vitale has been diagnosed with ...

Longtime ESPN college basketball broadcaster Dick Vitale has been diagnosed with melanoma, the fifth time that he’s had to deal with cancer. ESPN released a statement Monday on social media in which ...

Dick Vitale's latest biopsy has brought some bad news. In a statement shared by ESPN's PR account on X (formerly Twitter), the legendary college basketball analyst announced on Monday, April 13 that ...

Dick Vitale will soon start immunotherapy treatments. Randy Sartin / USA Today via Imagn Images ESPN college basketball broadcaster Dick Vitale announced Monday that he has been diagnosed with ...

Share on Pinterest Evidence suggests that AI tools assisting dermatologists can improve diagnostic performance for skin cancer. Image credit: PER Images/Stocksy A study suggests that artificial ...

PORTLAND, Ore. — Oregon State University researchers have discovered a new way to treat melanoma, which is the most dangerous type of skin cancer. Skin cancer as a whole is the most common type of ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Could something like a warm plaster one day treat skin cancer?

Computer-aided drug design using the SILCS technology identified three sites on HIF-2 that are highly similar in HIF-1 and HIF-2 and are suitable for targeting with small molecule inhibitors.

Explore the latest statistics on cutaneous melanoma: why incidence rates are rising by 1.2% annually while mortality is dropping, and how biomarkers are driving personalized care. Cutaneous melanoma ...